Medlive Technology (02192) Announces Monthly Share Capital Movements for November 2025

Bulletin Express
Dec 01, 2025

Medlive Technology Co., Ltd. (Stock Code: 02192) published its monthly return for the period ended 30 November 2025. The authorized share capital remained at 50,000,000,000 ordinary shares, each valued at USD 0.00001, maintaining a total authorized share capital of USD 500,000.

The total issued shares likewise stood at 734,793,375, showing no movements during the reporting period. Under the Pre-IPO Share Option Scheme, 5,481,125 share options remained outstanding; no new shares were issued, and the Post-IPO Share Option Scheme indicated that 69,017,600 shares may be issued upon exercise of granted options.

The company confirmed compliance with relevant listing rules and regulations. No other changes in treasury shares or warrant-related movements were announced for November 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10